Qube Research & Technologies LTD Gt Biopharma, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$0.24 - $0.35 $0 - $0
2 New
2 $0
Q3 2022

Nov 14, 2022
SELL
$1.81 - $56.1 $649 - $20,139
-359 Reduced 2.36%
14,867 $26,000
Q2 2022

Aug 15, 2022
BUY
$1.64 - $3.11 $24,970 - $47,352
15,226 New
15,226 $46,000
Q4 2021

Feb 01, 2022
SELL
$3.05 - $7.08 $43,660 - $101,350
-14,315 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$6.68 - $15.26 $95,624 - $218,446
14,315 New
14,315 $96,000

Others Institutions Holding GTBP

# of Institutions
4
Shares Held
564
Call Options Held
0
Put Options Held
0
View Full List

About GT Biopharma, Inc.

GTBP Quotes by TradingView
  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $81.7M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email